Scientists who want a say in the future of their inventions are once again moving from academia to the C-suite ...

An analyst note raising questions about Amgen’s MariTide triggered a stock sell-off Tuesday. Elsewhere, Roche and Novartis ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Profit after tax came in ₹38.4 crore in Q2 of FY25, a recovery from a net loss of ₹11.8 crore in the first quarter of this ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good day everyone and welcome to today’s Avadel Pharmaceuticals ...

AstraZeneca’s growth was driven by its portfolio of products in the oncology, biopharmaceuticals and rare disease segments ...

Recent health news highlights include Amgen addressing bone density concerns, AstraZeneca revising its financial outlook ...

Universe Pharmaceuticals INC (NASDAQ: UPC) ("Universe Pharmaceuticals” or the "Company”), a pharmaceutical producer and distributor in China, today announced that the Company plans to effect a share ...

A Baltimore jury found two drug distributors liable for contributing to the city's ongoing opioid crisis. The decision came ...

Neimeth International Pharmaceuticals Plc has announced the appointment of Ms. Patricia Aderibigbe and Mr. Adeyemi Odusanya as Independent Non-Executive Directors.

British drugmaker AstraZeneca increased its full-year sales outlook on booming demand for its cancer and rare-disease drugs, and said it plans to invest $3.5 billion in its U.S. business by the end of ...